LITTLE ROCK, Ark.--(BUSINESS WIRE)--Kelyniam Global, Inc. (OTCBB:KLYG), an advanced Engineering and Rapid Prototyping Company proudly announces today that the Company has received a research grant of $50,000.00 from the State of Connecticut through the Department of Economic and Community Development (DECD). After six months of review and research into Kelyniam Engineering’s business plan, the Connecticut Center of Advanced Technology has made a recommendation to the DECD for approval. The proceeds will be used to purchase additional high technology Laser equipment necessary for our Bio-CADCAM research.
James Ketner, President/CEO stated: “This grant will allow Kelyniam to purchase specialized equipment in order for us to continue our research of Bio-CADCAM technology. The initial use of this new equipment will be for the inspection and quality control of our new cranial implant products. Advances in laser and digital camera technology will allow for a whole new way for verifying organic shapes and to be able to replicate them with a high degree of accuracy.”
The research and development of this new technology will be performed at our recently acquired state-of-the-art CADCAM facility in New Britain Connecticut.
More information about Kelyniam Engineering can be found by following the links provided on our newly updated website at (www.kelyniam.com).
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Kelyniam Global, Inc. intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes’’ “seeks,” “estimates,” or variations of such words are intended to identify such forward-looking statements. Additional uncertainties and risks are described in Kelyniam Global, Inc.’s most recently filed SEC documents at www.sec.gov. All forward-looking statements are based upon information available to Kelyniam Global, Inc. on the date hereof. Kelyniam Global, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Kelyniam Global, Inc.
Michelle LynRay, 1-800-280-8192
www.kelyniam.com
285.67 (3.02%)
